Clinical trial tracker
Every compound in the The Modern Health Report research library, ordered by how far it has actually progressed in human research — FDA approved, then Phase 3, 2, 1 and preclinical. Trial records come straight from ClinicalTrials.gov and are refreshed daily. Investigational compounds are not approved medicines, and nothing here is dosing guidance.
Registry data last refreshed 21 Sept 2026.
New registrations, recruitment-status changes, posted results and our latest reporting — newest first.
📰 Latest reporting · 20 Sept 2026
GLP-1 medicines after bariatric surgery: what the new research is asking
A closer look at a planned tirzepatide trial, semaglutide weight tracking and the evidence still needed to guide treatment after surgery.
Semaglutide
📰 Latest reporting · 18 Sept 2026
Where Peptide Regulation Actually Stands After the July 2026 FDA Votes
An advisory committee voted to recommend BPC-157, TB-500, KPV and MOTS-c for compounding. That is not approval, and it is not permission. Here is the exact position as of September 2026.
BPC-157
📰 Latest reporting · 24 Jul 2026
Retatrutide Passes Two More Phase 3 Trials — and What TRIUMPH-3 Did Not Show
Up to 20.8% and 22.6% weight loss at 80 weeks in two more pivotal trials. The number that was not in the headline matters just as much.
Retatrutide
Approved by the FDA for at least one specific indication.
Wegovy; Ozempic; Rybelsus
10 recently updated registry records
Zepbound; Mounjaro
10 recently updated registry records
Egrifta
10 recently updated registry records
10 recently updated registry records
Bremelanotide, Vyleesi
10 recently updated registry records
VIP; synthetic form: aviptadil
10 recently updated registry records
Levocarnitine; Carnitor
10 recently updated registry records
Afamelanotide; MT-1; the active peptide in Scenesse
10 recently updated registry records
Large randomised trials testing efficacy and safety before any approval decision.
LY3437943; sometimes mislabelled 'GLP-3'
10 recently updated registry records
AM833; the amylin component of CagriSema
10 recently updated registry records
Zadaxin
10 recently updated registry records
10 recently updated registry records
Mid-size trials testing whether the compound does anything useful, and at what exposure.
Delta sleep-inducing peptide
10 recently updated registry records
GSH; gamma-glutamyl-cysteinyl-glycine
10 recently updated registry records
Long R3 insulin-like growth factor 1
10 recently updated registry records
Cibinetide; pyroglutamate helix B surface peptide (pHBSP)
4 recently updated registry records
3 recently updated registry records
5-amino-1-methylquinolinium; 5A1MQ
No registry records matched this compound
No registry records matched this compound
Small first-in-human safety and tolerability studies.
KISS1 peptides; kisspeptin-54 and kisspeptin-10
10 recently updated registry records
Cell and animal research only — no registered human efficacy programme.
Thymosin beta-4 fragment
10 recently updated registry records
Elamipretide
10 recently updated registry records
10 recently updated registry records
10 recently updated registry records
9 recently updated registry records
Body Protection Compound 157, pentadecapeptide BPC 157
4 recently updated registry records
Copper tripeptide-1
2 recently updated registry records
Modified GRF (1-29); with DAC
1 recently updated registry record
No registry records matched this compound
Epithalon
No registry records matched this compound
Sourcing recommendation
For readers who need a vetted research-peptide supplier, we use Certiva Biologics. Their products are sold for research use only and are not for human consumption.
Certiva Biologics lists 99%+ purity and ships a Certificate of Analysis with every lot. Each batch is third-party tested, and the latest COA is available to review before ordering. They carry research peptides including tirzepatide, semaglutide and investigational retatrutide.
Visit www.certivabiologics.comTo view the peptide catalog, open the site menu and go to Member home.
This is our supplier of choice, not a medical recommendation. Research peptides are not approved for human consumption in many jurisdictions. Verify the latest COA, local regulations, and discuss any use with a qualified clinician.
